{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:23:50Z","timestamp":1787829830394,"version":"build-2784847793"},"reference-count":53,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Cardiac sarcoidosis (CS) is a potentially life-threatening manifestation of systemic granulomatous disease, characterized by a heterogeneous spectrum of arrhythmic and conduction disorders that represent the leading cause of CS-related sudden cardiac death (SCD). Clinical cardiac involvement is estimated at 5% of sarcoidosis patients, while silent myocardial infiltration is detected in 20\u201325% of autopsy series. Diagnosis is difficult because the disease frequently runs a subclinical course and no single test is pathognomonic. Methods: PubMed and Embase were searched to 5 August 2026 for this narrative review, incorporating peer-reviewed articles, international guidelines (HRS 2014, JCS 2016, AHA\/ACC\/HRS 2017, ESC 2022, AHA 2024, the 2024 European clinical consensus statement and the 2025 ESC guidelines on myocarditis and pericarditis), and registry data. Results: Atrioventricular (AV) block occurs in 23\u201330% of CS patients and frequently requires permanent pacing. Fatal ventricular arrhythmia rates reach 20.7% at 5 years and 31.9% at 10 years (ILLUMINATE-CS registry, n = 512). Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) performs well diagnostically (pooled sensitivity 95%, specificity 85%) and is associated with an odds ratio of 10.74 for arrhythmic events. 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) provides complementary value for guiding immunosuppressive therapy and pre-ablation risk assessment. Implantable loop recorders enable early arrhythmia detection in patients not yet meeting implantable cardioverter-defibrillator (ICD) criteria. Conclusion: Optimal management of arrhythmias in CS requires a multimodal diagnostic approach integrating electrocardiography, advanced cardiac imaging, and continuous rhythm monitoring. Risk stratification for SCD remains the central challenge, requiring individualized decision-making that integrates left ventricular ejection fraction (LVEF), imaging biomarkers, and electrophysiological data. Future prospective studies should aim to refine predictive risk algorithms, assess the role of emerging immunomodulatory agents such as JAK\/STAT inhibitors, and validate artificial intelligence (AI)-assisted tools intended to identify cardiac involvement and arrhythmic risk earlier in the disease course.<\/jats:p>","DOI":"10.3390\/jcm15176619","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:58:21Z","timestamp":1787828301000},"page":"6619","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Arrhythmias in Cardiac Sarcoidosis: Pathophysiology, Diagnostic Strategies, Risk Stratification for Sudden Cardiac Death, and Contemporary Management\u2014A Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"given":"Mehdi","family":"Guedira","sequence":"first","affiliation":[{"name":"Cardiology Department, Groupe Hospitalier Sud \u00cele-de-France (GHSIF), 270 Avenue Marc Jacquet, 77011 Melun, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaouad","family":"Nguadi","sequence":"additional","affiliation":[{"name":"Cardiology Department, Groupe Hospitalier Sud \u00cele-de-France (GHSIF), 270 Avenue Marc Jacquet, 77011 Melun, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Poindron","sequence":"additional","affiliation":[{"name":"Cardiology Department, Rythmos, Clinique Les Fontaines Melun, 77000 Melun, France"},{"name":"Cardiology Department, Rythmos, H\u00f4pital Priv\u00e9 d\u2019Antony, 92160 Antony, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lellouche","sequence":"additional","affiliation":[{"name":"Cardiology Department, H\u00f4pital Henri Mondor, 94000 Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7237-6064","authenticated-orcid":false,"given":"Cyrus","family":"Moini","sequence":"additional","affiliation":[{"name":"Cardiology Department, Groupe Hospitalier Sud \u00cele-de-France (GHSIF), 270 Avenue Marc Jacquet, 77011 Melun, France"},{"name":"Cardiology Department, Rythmos, Clinique Les Fontaines Melun, 77000 Melun, France"},{"name":"Cardiology Department, Rythmos, H\u00f4pital Priv\u00e9 d\u2019Antony, 92160 Antony, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccm.2008.03.014","article-title":"The immunology of sarcoidosis","volume":"29","author":"Gerke","year":"2008","journal-title":"Clin. Chest Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/hearts2020019","article-title":"Cardiac Sarcoidosis: Pathophysiology, Diagnosis, and Management","volume":"2","author":"Kayali","year":"2021","journal-title":"Hearts"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e1197","DOI":"10.1161\/CIR.0000000000001240","article-title":"Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement from the American Heart Association","volume":"149","author":"Cheng","year":"2024","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jcmg.2022.02.025","article-title":"Incidence and Predictors of Atrial Fibrillation in Cardiac Sarcoidosis","volume":"15","author":"Uusitalo","year":"2022","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.23736\/S2724-5683.25.06725-0","article-title":"Atrial cardiomyopathy: New pathophysiological and clinical aspects","volume":"74","author":"Pierucci","year":"2026","journal-title":"Minerva Cardiol. Angiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12149-019-01431-z","article-title":"Diagnosis of cardiac sarcoidosis: An era of paradigm shift","volume":"34","author":"Sharma","year":"2020","journal-title":"Ann. Nucl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5582\/irdr.2015.01023","article-title":"Sarcoidosis and the heart: A review of the literature","volume":"4","author":"Ipek","year":"2015","journal-title":"Intractable Rare Dis. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1093\/eurheartj\/ehac323","article-title":"Risk stratification of patients with cardiac sarcoidosis: The ILLUMINATE-CS registry","volume":"43","author":"Nabeta","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Cherrett, C., Lee, W., Bart, N., and Subbiah, R. (2023). Management of the arrhythmic manifestations of cardiac sarcoidosis. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1104947"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.hrthm.2021.04.032","article-title":"The precordial R\u2032 wave: A novel discriminator between cardiac sarcoidosis and arrhythmogenic right ventricular cardiomyopathy in patients presenting with ventricular tachycardia","volume":"18","author":"Hoogendoorn","year":"2021","journal-title":"Heart Rhythm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e009203","DOI":"10.1161\/CIRCEP.120.009203","article-title":"Arrhythmias in Cardiac Sarcoidosis Bench to Bedside: A Case-Based Review","volume":"14","author":"Rosenfeld","year":"2021","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Arunachalam Karikalan, S., Yusuf, A., and El Masry, H. (2024). Arrhythmias in Cardiac Sarcoidosis: Management and Prognostic Implications. J. Clin. Med., 13.","DOI":"10.3390\/jcm13113165"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1148\/radiol.213170","article-title":"Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis","volume":"304","author":"Aitken","year":"2022","journal-title":"Radiology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1161\/01.CIR.94.12.3318","article-title":"Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction","volume":"94","author":"Kim","year":"1996","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/eurheartj\/ehae356","article-title":"Management of cardiac sarcoidosis","volume":"45","author":"Sharma","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_18","first-page":"481","article-title":"Variances of dietary preparation for suppression of physiological 18F-FDG myocardial uptake in the presence of cardiac sarcoidosis: A systematic review","volume":"27","author":"Turner","year":"2020","journal-title":"J. Nucl. Cardiol. Off. Publ. Am. Soc. Nucl. Cardiol."},{"key":"ref_19","first-page":"286","article-title":"Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: A randomized controlled trial","volume":"17","author":"Cheng","year":"2010","journal-title":"J. Nucl. Cardiol. Off. Publ. Am. Soc. Nucl. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e008975","DOI":"10.1161\/CIRCIMAGING.118.008975","article-title":"Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis","volume":"12","author":"Divakaran","year":"2019","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/ejhf.3545","article-title":"Endomyocardial biopsy in the diagnosis of cardiac sarcoidosis","volume":"27","author":"Lehtonen","year":"2025","journal-title":"Eur. J. Heart Fail."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cardfail.2026.02.025","article-title":"Positive endomyocardial biopsy in cardiac sarcoidosis: Predictors and outcomes from the Japanese ILLUMINATE-CS registry","volume":"32","author":"Maeda","year":"2026","journal-title":"J. Card. Fail."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jce.15191","article-title":"Electrogram-guided endomyocardial biopsy yield in patients with suspected cardiac sarcoidosis and relation to outcomes","volume":"32","author":"Ezzeddine","year":"2021","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.hrthm.2021.11.025","article-title":"Long-term monitoring of arrhythmias with cardiovascular implantable electronic devices in patients with cardiac sarcoidosis","volume":"19","author":"Bakker","year":"2022","journal-title":"Heart Rhythm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated with Cardiac Sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.acvd.2021.11.003","article-title":"Beyond the wrist: Using a smartwatch electrocardiogram to detect electrocardiographic abnormalities","volume":"115","author":"Ploux","year":"2022","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_27","first-page":"2329","article-title":"JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis\u2014Digest Version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","article-title":"2025 ESC guidelines for the management of myocarditis and pericarditis","volume":"46","author":"Collini","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s11936-012-0208-3","article-title":"Cardiac sarcoidosis: Diagnosis and management","volume":"14","author":"Bussinguer","year":"2012","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"ref_31","first-page":"1686","article-title":"Successful treatment of cardiac sarcoidosis with infliximab","volume":"35","author":"Barnabe","year":"2008","journal-title":"J. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1093\/rheumatology\/keae692","article-title":"Comparative effectiveness of disease-modifying antirheumatic drugs for patients with cardiac sarcoidosis","volume":"64","author":"Brooks","year":"2025","journal-title":"Rheumatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"108126","DOI":"10.1016\/j.rmed.2025.108126","article-title":"Durable remission of cardiac sarcoidosis following discontinuation of methotrexate: A prospective cohort study","volume":"243","author":"Alipour","year":"2025","journal-title":"Respir. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e021183","DOI":"10.1161\/JAHA.121.021183","article-title":"Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review","volume":"10","author":"Fazelpour","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/clc.4960270409","article-title":"Ventricular tachyarrhythmia associated with cardiac sarcoidosis: Its mechanisms and outcome","volume":"27","author":"Furushima","year":"2004","journal-title":"Clin. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCEP.112.971341","article-title":"Catheter Ablation of Ventricular Tachycardia in Nonischemic Heart Disease","volume":"5","author":"Tokuda","year":"2012","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00380-022-02136-6","article-title":"Atrioventricular block in the setting of cardiac sarcoidosis: Further implications","volume":"38","author":"Yalta","year":"2023","journal-title":"Heart Vessels"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s00380-020-01584-2","article-title":"Detection of arrhythmogenic substrate within QRS complex in patients with cardiac sarcoidosis using wavelet-transformed ECG","volume":"35","author":"Yodogawa","year":"2020","journal-title":"Heart Vessels"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Nelson, D., Alharbi, F., Tavoosi, A., Nery, P.B., Beanlands, R., and Birnie, D. (2026). High incidence of pacing-induced cardiomyopathy in patients with cardiac sarcoidosis. Heart Rhythm, epub ahead of print.","DOI":"10.1016\/j.hrthm.2026.03.1960"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jacep.2025.09.046","article-title":"Left bundle branch area pacing in patients with cardiac sarcoidosis","volume":"12","author":"Gurin","year":"2026","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"JCS Joint Working Group (2013). Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011). Circ. J., 77, 249\u2013274.","DOI":"10.1253\/circj.CJ-66-0054"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1111\/jce.15631","article-title":"Cardiac resynchronization therapy response in cardiac sarcoidosis","volume":"33","author":"Shabtaie","year":"2022","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_44","first-page":"682","article-title":"Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: A systematic review","volume":"20","author":"Papageorgiou","year":"2018","journal-title":"EP Eur."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamacardio.2021.4738","article-title":"Outcomes Associated with Catheter Ablation of Ventricular Tachycardia in Patients with Cardiac Sarcoidosis","volume":"7","author":"Siontis","year":"2022","journal-title":"JAMA Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10840-025-01986-0","article-title":"Outcomes of catheter ablation in cardiac sarcoidosis patients with ventricular tachycardia: A propensity score-matched retrospective analysis","volume":"68","author":"Saxena","year":"2025","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Skowasch, D., Ringquist, S., Nickenig, G., and Andri\u00e9, R. (2018). Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0194496"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.hrthm.2017.10.036","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"15","author":"Stevenson","year":"2018","journal-title":"Heart Rhythm"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic Value of Myocardial Scarring on CMR in Patients with Cardiac Sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1093\/eurheartj\/ehaf338","article-title":"Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: A comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placement","volume":"46","author":"Mathijssen","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e007488","DOI":"10.1161\/CIRCEP.119.007488","article-title":"Assessment of the 2017 AHA\/ACC\/HRS guideline recommendations for implantable cardioverter-defibrillator implantation in cardiac sarcoidosis","volume":"12","author":"Kazmirczak","year":"2019","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ahj.2019.10.003","article-title":"Cardiac sarcoidosis multi-center randomized controlled trial (CHASM CS-RCT)","volume":"220","author":"Birnie","year":"2019","journal-title":"Am. Heart J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jacep.2025.10.009","article-title":"Predicting sudden cardiac death in patients with sarcoidosis using a multimodal artificial intelligence model","volume":"12","author":"Lai","year":"2026","journal-title":"JACC Clin. Electrophysiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6619\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:14:14Z","timestamp":1787829254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":53,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15176619"],"URL":"https:\/\/doi.org\/10.3390\/jcm15176619","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}